From Regulatory Knowledge to Regulatory Decisions
The European Evaluation of Medicines
Datos Bibliográficos
| ID | 10282948 |
|---|---|
| Autores | Boris Hauray (0000-0001-6770-6903, Inserm, autor de correspondencia) |
| Año | 2017 |
| Volumen | 55 |
| Número | 2 |
| Páginas | 187-208 |
| Fecha de publicación | 2017-05-30 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Minerva (JOURNAL) |
| Identificadores de la revista | ISSN: 0026-4695 • E-ISSN: 1573-1871 |
| Editorial | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/s11024-017-9323-3 |
| OpenAlex | W2618145430 |
| Idioma | EN |
| Citas recibidas | 11 |
| Referencias citadas | 39 |
Agency (philosophy · Business · Objectivity (philosophy · Political science · Politics · Public relations · Regulatory agency · Regulatory science · Social science · Sociology · Sociology of scientific knowledge · Health Systems, Economic Evaluations, Quality of Life · Law · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Public Administration
“Health for all” and the challenges for pharmaceutical policies
Opening the ‘Black Box’ of Regulation-making for Bottled Water Quality Standards in India
Changing standards for drug approval
Nano-hydroxyapatite Before the Science Court
Dispositifs de transparence et régulation des conflits d’intérêts dans le secteur du médicament
The Rise of Global Health Emergency Governance
Expertise, Regulatory Science and the Evaluation of Technology and Risk
Making vaccines investable in preclinical vaccine R&D
Is regulatory innovation fit for purpose? A case study of adaptive regulation for advanced biotherapeutics
Un transhumanisme ' à mains nues
Science under Covid-19's magnifying glass
Scientists and the Regulation of Risk
Reputation and Power
Global Business Regulation
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
From drug crises to regulatory change
A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation
Ways of Regulating Drugs in the 19th and 20th Centuries
When Experiments Travel
The Rule of Non‐Opposition
Pharmacopolitics
Progress, Innovation and Regulatory Science in Drug Development
Biomedical Conventions and Regulatory Objectivity
Global Business Regulation
Is Republican Regulatory Law the Answer to Globalization
Mutual transformation and the development of European policy spaces. The case of medicines licensing
Risk and Blame
Groups, the Media, Agency Waiting Costs, and FDA Drug Approval
Science on Stage
Deficits, Expectations and Paradigms in British and American Drug Safety Assessments
Democracy, Technocracy, and the Secret State of Medicines Control
Commensuration as a Social Process
| Obras citantes distintas | 11 |
|---|---|
| Citas por año | 1,22 |
| Intervalo de citas | 2017 - 2026 (10) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 11 |